IMMUNE-MEDIATED MYOCARDITIS

This adverse event was reported 1616 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED MYOCARDITIS:

# Drug Count
0 PEMBROLIZUMAB 779
1 NIVOLUMAB 508
2 IPILIMUMAB 288
3 CARBOPLATIN 196
4 PACLITAXEL 137
5 PACLITAXEL (AIBUMIN-BOUND) 130
6 DURVALUMAB 113
7 DOXORUBICIN 79
8 PEMETREXED DISODIUM 77
9 CISPLATIN 70
See all common drugs associated with IMMUNE-MEDIATED MYOCARDITIS

IMMUNE-MEDIATED MYOCARDITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ACETAMINOPHEN TABLETS 500 MG 1 0.1429
1 ADENINE 1 0.0204
2 PENPULIMAB 2 0.0204
3 NIVOLUMAB AND RELATLIMAB-RMBW 6 0.0117
4 TREMELIMUMAB 45 0.0102
5 NIVOLUMAB AND HYALURONIDASE-NVHY 1 0.0074
6 PEMBROLIZUMAB 779 0.0072
7 IPILIMUMAB 288 0.0066
8 HETASTARCH 1 0.0059
9 DOSTARLIMAB 14 0.0056
See all drugs enriched for association with IMMUNE-MEDIATED MYOCARDITIS